Cargando…
European NSTEMI guidelines—return of clopidogrel?
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724138/ https://www.ncbi.nlm.nih.gov/pubmed/34528121 http://dx.doi.org/10.1007/s00228-021-03200-2 |
| _version_ | 1784625862069452800 |
|---|---|
| author | Dannenberg, Lisa M’Pembele, René Metzen, Daniel Petzold, Tobias Zeus, Tobias Kelm, Malte Polzin, Amin |
| author_facet | Dannenberg, Lisa M’Pembele, René Metzen, Daniel Petzold, Tobias Zeus, Tobias Kelm, Malte Polzin, Amin |
| author_sort | Dannenberg, Lisa |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8724138 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87241382022-01-13 European NSTEMI guidelines—return of clopidogrel? Dannenberg, Lisa M’Pembele, René Metzen, Daniel Petzold, Tobias Zeus, Tobias Kelm, Malte Polzin, Amin Eur J Clin Pharmacol Letter to the Editor Springer Berlin Heidelberg 2021-09-15 2022 /pmc/articles/PMC8724138/ /pubmed/34528121 http://dx.doi.org/10.1007/s00228-021-03200-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter to the Editor Dannenberg, Lisa M’Pembele, René Metzen, Daniel Petzold, Tobias Zeus, Tobias Kelm, Malte Polzin, Amin European NSTEMI guidelines—return of clopidogrel? |
| title | European NSTEMI guidelines—return of clopidogrel? |
| title_full | European NSTEMI guidelines—return of clopidogrel? |
| title_fullStr | European NSTEMI guidelines—return of clopidogrel? |
| title_full_unstemmed | European NSTEMI guidelines—return of clopidogrel? |
| title_short | European NSTEMI guidelines—return of clopidogrel? |
| title_sort | european nstemi guidelines—return of clopidogrel? |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724138/ https://www.ncbi.nlm.nih.gov/pubmed/34528121 http://dx.doi.org/10.1007/s00228-021-03200-2 |
| work_keys_str_mv | AT dannenberglisa europeannstemiguidelinesreturnofclopidogrel AT mpembelerene europeannstemiguidelinesreturnofclopidogrel AT metzendaniel europeannstemiguidelinesreturnofclopidogrel AT petzoldtobias europeannstemiguidelinesreturnofclopidogrel AT zeustobias europeannstemiguidelinesreturnofclopidogrel AT kelmmalte europeannstemiguidelinesreturnofclopidogrel AT polzinamin europeannstemiguidelinesreturnofclopidogrel |